E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with G
>
Issuers starting with G, BK only
>
All stories on Gilead Sciences Inc.
>
Stories on Gilead Sciences Inc., BK only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Gilead Sciences Inc.
11/13/2024
BKIG
Moody’s rates Gilead notes A3
9/7/2023
BKIG
Moody's assigns A3 to Gilead notes
5/18/2023
BKIG
S&P revises Gilead outlook to positive
8/4/2022
BKIG
Moody's alters Gilead outlook to stable
10/27/2020
BKIG
S&P cuts Gilead
9/23/2020
BKIG
Moody’s assigns A3 to Gilead notes
9/22/2020
BKIG
S&P rates Gilead notes, loans A
9/14/2020
BKIG
S&P puts Gilead on watch
9/14/2020
BKIG
Gilead eyes $6 billion new debt to finance acquisition of Immunomedics
9/14/2017
BKIG
S&P: Gilead Sciences notes A
9/13/2017
BK
Gilead enters term loans totaling $6 billion for Kite acquisition
8/28/2017
BKBWIG
Gilead to take on bank debt, issue senior notes for Kite acquisition
1/17/2012
BK
Gilead enters into three new credit facilities totaling $3 billion
11/21/2011
BKIG
Gilead Sciences to use loans, notes, cash for Pharmasset acquisition
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
